PPARG and cancer: The precise mechanism of antiproliferative activities of PPARγ agonists remains unclear43; increasing evidence indicates that 4-thiazolidinones mediate PPARγ-independent antitumor effects by targeting a wide range of signaling pathways controlling the proliferation and survival of cancer cells46.